Stocks and Investing Stocks and Investing
Fri, May 17, 2024

Connor Chamberlain Maintained (CDNA) at Strong Buy with Increased Target to $22 on, May 17th, 2024


Published on 2024-10-28 11:26:51 - WOPRAI, Connor Chamberlain
  Print publication without navigation


Connor Chamberlain of Craig-Hallum, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Increased Target from $15 to $22 on, May 17th, 2024.

Connor has made no other calls on CDNA in the last 4 months.



There are 5 other peers that have a rating on CDNA. Out of the 5 peers that are also analyzing CDNA, 2 agree with Connor's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yi Chen of "HC Wainwright & Co." Reiterated at Hold on, Wednesday, May 15th, 2024
  • Andrew Cooper of "Raymond James" Downgraded from Buy to Hold on, Monday, May 13th, 2024


These are the ratings of the 3 analyists that currently disagree with Connor


  • Mason Carrico of "Stephens & Co." Maintained at Buy with Increased Target to $18 on, Monday, May 13th, 2024
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Monday, May 13th, 2024
  • Alexander Nowak of "Craig-Hallum" Upgraded from Hold to Strong Buy and Increased Target to $15 on, Wednesday, May 1st, 2024

Contributing Sources